206 - Fungal Meningitis

Monday, October 20, 2025

3:15 PM - 3:40 PM US ET

Location: B405-B407

Speaker(s)

TW

Thomas J. Walsh, MD, PhD (Hon), FIDSA, FAAM, FECMM

Founding Director
Center for Innovative Therapeutics and Diagnostics (citdx.org)
Richmond, VA, United States

Disclosure(s):

Tom Walsh: Allergan: Advisor/Consultant, Grant/Research Support; Astellas: Advisor/Consultant, Grant/Research Support; Basilea: Advisor/Consultant; F2G: Advisor/Consultant, Grant/Research Support; Gilead: Advisor/Consultant, Grant/Research Support; Karyopharm: Advisor/Consultant, Advisor/Consultant, Grant/Research Support; Leadiant: Advisor/Consultant, Grant/Research Support; Merck: Advisor/Consultant, Grant/Research Support; Partner Therapeutics, Inc.: Advisor/Consultant; Scynexis: Advisor/Consultant, Grant/Research Support; Shionogi: Advisor/Consultant, Grant/Research Support; Statera: Advisor/Consultant; T2Biosystems: Advisor/Consultant, Grant/Research Support; Viosera: Grant/Research Support